［1］Siegel RL， Miller KD， Jemal A. Cancer Statistics，2018\[J\]. CA Cancer J Clin， 2018， 68（1）: 7-30.［2］Ohno Y， Koyama H， Yoshikawa T， et al. Standard，reduced，and nodose thinsection radiologic examinations: comparison of capability for nodule detection and nodule type assessment in patients suspected of having pulmonary nodules\[J\]. Radiology，2017， 284（2）: 562-573.［3］Siegel RL，Miller KD，Jemal A. Cancer Statistics，2017［J］. CA Cancer J Clin， 2017， 67（1）: 7-30.［4］Witt C. European Respiratory Society/American Thoracic Society/International Association for the Study of Lung Cancer International Multidisciplinary Classification of Lung Adenocarcinoma: State of the Art\[J\]. J Thorac Oncol，2011， 6（8）: 1451.［5］邸丽娟，王荣福，张建华，等. 18FFDG PET/CT半定量参数SUVmax对肾透明细胞癌分级分期的预测价值\[J\]. 肿瘤学杂志， 2017， 23（4）: 295-299.［6］Win AZ， Aparici CM. Clinical effectiveness of （18）Ffluorodeoxyglucose positron emission tomography/computed tomography in management of renal cell carcinoma: a single institution experience\[J\]. World J Nucl Med， 2015， 14（1）: 36-40.［7］张敬勉， 赵新明， 王建方， 等. 18FFDG PET/CT显像在淋巴瘤治疗疗效评价中的价值\[J\]. 肿瘤学杂志， 2012， 18（3）: 198-201.［8］Park SY， Cho A，Yu WS，et al. Prognostic value of total lesion glycolysis by 18FFDG PET/CT in surgically resected stage IA nonsmall cell lung cancer\[J\]. Nucl Med，2015，56（l）: 45-49.［9］Ettinger DS，Wood DE，Akerley W，et al. NCCN guidelines insights: nonsmall cell lung cancer，version 4. 2016\[J\]. J Natl Compr Canc Netw，2016，4（3）: 255-264.［10］Hyun SH，Ahn HK，Kim H，et al. Volumebased assessment by （18）FFDG PET/CT predicts survival in patients with stage Ⅲ nonsmallcell lung cancer\[J\]. Eur Nucl Med Mol Imaging, 2014，41（l）: 50-58.［11］Liao S，Penney BC，Wroblewski K，et al. Prognostic value of metabolic tumor burden on 18FFDG PET in nonsurgical patients with nonsmall cell lung cancer\[J\]. Eur Nucl Med Mol Imaging，2012，39（l）: 27-38.［12］Domachevsky L，Groshar D，Galili R，et al. Survival prognostic value of morphological and metabolic variables in patients with stage Ⅰ and Ⅱ nonsmall cell lung cancer\[J\]. Eur Radiol，2015，25（11）: 3361-3367.［13］Yoo IeR，Chung SK，Park HI， et al. Prognostic value of SUVmax and metabolic tumor volume on 18FFDG PET/CT in early stage nonsmall cell lung cancer patients without LN metastasis\[J\]. Biomed Mater Eng，2014，4（6）: 3091-3103.［14］Lin Y，Lin WY，Kao CH，et al. Prognostic value of preoperative metabolic tumor volumes on PETCT in predicting diseasefree survival of patients with stage Ⅰ nonsmall cell lung cancer\[J\]. Anticancer Res，2012，32（11）: 5087-5091.［15］Takahashi M，Kume H，Koyama K，et al. Preoperative evaluation of renal cell carcinoma by using 18FFDG PET/CT\[J\]. Clin Nucl Med，2015，40（12）: 936-940.［16］Scott WJ， Schwabe JL， Gupta NC， et al. Positron emission tomography of lung tumors and mediastinal lymph nodes using\[18F\] fluorodeoxyglucose\[J\]. Ann Thorac Surg，1994， 58(3): 698-703.［17］Patz EF Jr， Lowe VJ， Hoffman JM， et al. Focal pulmonary abnormalities: evaluation with F18 fluorodeoxyglucose PET scanning\[J\]. Radiology， 1993， 188（2）: 487-490.［18］Noguchi M， Morikawa A， Kawasaki M， et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis\[J\]. Cancer， 1995， 75（12）: 2844-2852.［19］左玉强，孟庆春，田云霞，等. 纯磨玻璃密度浸润前病变与浸润性肺腺癌的临床及CT鉴别\[J\]. 重庆医学，2017，46（13）: 1782-1785.［20］金鑫，赵绍宏，高洁，等. 纯磨玻璃密度肺腺癌病理分类及影像表现特点分析\[J\]. 中华放射学杂志，2014，48（4）: 283-287.［21］陈天忠，韦乐心，余绍立，等. 多层螺旋CT对肺磨玻璃结节与支气管关系的初探\[J\]. 临床放射学杂志，2014，33（5）: 711-715.［22］潘江峰，邝平定，应明亮，等. 肺部纯磨玻璃结节浸润性肺腺癌与浸润前病变的高分辨靶扫描CT鉴别诊断\[J\]. 浙江医学，2016，38（11）: 826-828.［23］张辉，唐嘉励，段东. 18FFDG PET/CT结合同机HRCT对磨玻璃结节的诊断价值\[J\]. 国际放射医学核医学杂志，2017， 41（4）: 241-246.
2019, Vol. 29 
